• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.63% Nasdaq Up0.42%

    Bio-Techne Corp. (TECH)

    97.89 Down 0.58(0.59%) 12:34PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Bio-Techne Corp.
    614 McKinley Place North East
    Minneapolis, MN 55413
    United States - Map
    Phone: 612-379-8854
    Website: http://www.techne-corp.com

    Index Membership:N/A
    Full Time Employees:967

    Business Summary 

    Bio-Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. The Biotechnology segment provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits used by researchers to quantify the level of a specific protein in biological fluids, such as serum, plasma, or urine; and clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays for use as in vitro diagnostic devices. This segment also offers flow cytometry products, such as fluorochrome labeled antibodies and kits for use in determining the immuno-phenotypic properties of cells from various tissues; and natural and synthetic chemical compounds for use by investigators as agonists, antagonists, and/or inhibitors of various biological functions. The Clinical Controls segment provides a range of hematology controls and calibrators for impedance and laser type cell counters; and hematology control products for use as proficiency testing tools by laboratory certifying authorities. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Bio-Techne Corp.

    Corporate Governance 
    Bio-Techne Corp.’s ISS Governance QuickScore as of Jun 1, 2015 is 3. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 1; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Charles R. Kummeth , 55
    Chief Exec. Officer, Pres and Director
    Mr. James T. Hippel , 44
    Chief Financial Officer and VP of Fin.
    Dr. J. Fernando Bazan Ph.D., 55
    Chief Technical Officer
    Mr. Marcel Veronneau , 61
    Sr. VP of Clinical Controls
    Ms. Brenda S. Furlow J.D., 55
    Sr. VP and Gen. Counsel
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders